Jacobs Levy Equity Management, Inc Logic Bio Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

  • $24.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$6.8 - $9.16 $137,666 - $185,444
-20,245 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$5.29 - $9.1 $227,343 - $391,081
-42,976 Reduced 67.98%
20,245 $154,000
Q3 2020

Nov 16, 2020
BUY
$5.41 - $9.45 $279,799 - $488,744
51,719 Added 449.65%
63,221 $574,000
Q2 2020

Aug 17, 2020
BUY
$4.25 - $8.46 $48,883 - $97,306
11,502 New
11,502 $97,000

About LogicBio Therapeutics, Inc.

LOGC Quotes by TradingView
  • Ticker LOGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,962,700
  • Description
  • LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...
More about LOGC
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email